Minerals Technologies earnings beat by $0.02, revenue topped estimates

Minerals Technologies (MTX) reported Q3 EPS of $1.53, beating estimates by $0.02, with revenue of $554.9M, slightly above consensus. The stock is down 18.90% over 3 months but up 11.93% year-over-year. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Oct 29, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MTX
Bullish
medium confidence
Mentioned
$MTX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MTXBullishMed
01

Why it matters

EPS and revenue both slightly exceeded consensus, which typically supports the stock, but the lack of guidance or other forward-looking disclosures limits conviction.

02

Market read

This is a company-specific earnings beat update that can influence short-term positioning, though the magnitude appears modest and no forward catalyst is cited.

03

What to watch

Without details on segment performance, margins, backlog, or guidance, traders may overreact to the beat and then fade the move if fundamentals disappoint later.

Relevance 7/10Novelty 7/10Timing: after-hours/earnings release reported for Q3 (published 2026-10-29 21:30:49+00:00)

Background

The piece is an earnings print summary for Minerals Technologies’ third quarter results versus analyst consensus.

Company-level read

Ticker impact

$MTXBullishMedium confidence
Context

Minerals Technologies reported Q3 EPS of $1.53, beating the $1.51 estimate, and revenue of $554.9M versus $553.78M consensus.

Expected impact

Likely mild upward bias as the market digests the beat, with limited follow-through risk given the small upside versus consensus.

Evidence & confidence

The beat is quantified (EPS and revenue) but there is no mention of guidance, margins, or forward-looking surprises; revisions are mixed (0 positive, 3 negative in 90 days).

Market effects

Provides a datapoint for industrial/minerals-related demand expectations, but no sector-wide read-through is provided.

No specific regional macro or supply-chain shock is discussed.

No global commodity or cross-border policy linkage is mentioned beyond company results.

Counterpoint

The beat is small and the article notes negative EPS revisions recently, which can cap the upside despite the headline EPS and revenue outperformance.

Key entities

  • Minerals Technologies

    NYSE-listed industrial/minerals company reporting Q3 EPS and revenue versus consensus.

Related articles

$MTXMed

Minerals Technologies Inc (MTX) (Q3 2026) Earnings Call Highlights: Sales Rise 4%

Minerals Technologies Inc (MTX) reported Q3 2026 sales up 4%, but operating income of $72M missed guidance due to cost inflation in Consumer & Specialties. Q4 sales are expected to decline ~10% sequentially to ~$525M, with operating income of $60-63M. Margins are expected to recover in 2027 as pricing catches up with inflation. MTX sees growth opportunities in high-purity calcium metal and steel slag, with incremental revenue of $100M over 3-5 years.

$MTXHighAI 8/10

What Minerals Technologies (MTX) Said on Its Q3 Earnings Call

Minerals Technologies (MTX) reported Q3 sales of $363M, up 11% in Environmental & Infrastructure and 1% in Consumer & Specialties. FLUORO-SORB product gained traction. Q4 sales expected to decline 10% sequentially. Cost pressures in Consumer & Specialties due to energy and transportation costs. Full-year free cash flow expected at 6% of sales. Dividend increased by 8%. MTX expects $525M in Q4 sales and EPS of $1.15-$1.20.

$MTXMed

Minerals Technologies (MTX) Q3 2026 Earnings Call Transcript

Minerals Technologies (MTX) reported Q3 2026 earnings with $555M in sales, a 4% YoY increase. Engineered Solutions segment grew 9% with strong margins, while Consumer and Specialty faced cost pressures. Operating income was $72M, EPS $1.53. The company raised its dividend by 8% and expects mid-single-digit revenue growth through 2027. Cash from operations rose 32% YoY to $171M.